Inventor · disambiguated record
Ulrich Goepfert
Also filed as: GOEPFERT ULRICH
25 granted patents·19 pending applications·165 citations·filing 2006–2025
95Inventor score
Top patents by PatentIndex Score
44 records- 0197US10323089B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2017·Granted Jun 18, 2019·25 cites·9 claims
- 0295US11584793B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2019·Granted Feb 21, 2023·8 cites·20 claims
- 0395US10941205B2Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Granted Mar 9, 2021·10 cites·13 claims
- 0494US12252533B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2022·Granted Mar 18, 2025·1 cites·11 claims
- 0594US8771988B2Protein expression from multiple nucleic acidsGOEPFERT ULRICH·Filed 2008·Granted Jul 8, 2014·36 cites·11 claims
- 0692US9290567B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesHOFFMANN LA ROCHE·Filed 2013·Granted Mar 22, 2016·25 cites·2 claims
- 0791US11603411B2Bispecific anti-human CD20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Granted Mar 14, 2023·9 cites·5 claims
- 0891US10822402B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Nov 3, 2020·4 cites·12 claims
- 0990US12030952B2Bispecific anti-human CD20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted Jul 9, 2024·1 cites·10 claims
- 1090US8609097B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesBOHRMANN BERND·Filed 2010·Granted Dec 17, 2013·28 cites·10 claims
- 1188US11787868B2Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Oct 17, 2023·1 cites·5 claims
- 1285US9862763B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jan 9, 2018·4 cites·13 claims
- 1385US2025297025A1Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1484US12297263B2Humanized anti-Tau(PS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 1584US10251952B2Humanized anti-tau(pS422) antibody brain shuttles and use thereofHOFFMANN LA ROCHE·Filed 2016·Granted Apr 9, 2019·5 cites·22 claims
- 1683US2023365702A1Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1782US9562091B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Feb 7, 2017·4 cites·10 claims
- 1882US2024317879A1Bispecific anti-human cd20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1981US12358997B1Bispecific anti-human A-beta/anti-human transferrin receptor antibodiesHOFFMANN LA ROCHE·Filed 2025·Granted Jul 15, 2025·0 cites·2 claims
- 2080US10465000B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Nov 5, 2019·2 cites·6 claims
- 2172US11572404B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Feb 7, 2023·0 cites·6 claims
- 2271US2025154249A1Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2368US11332797B2Method for the selection of a long-term producing cell using histone acylation as markersHOFFMANN LA ROCHE·Filed 2015·Granted May 17, 2022·1 cites·15 claims
- 2467US9428766B2Protein expression from multiple nucleic acidsHOFFMANN LA ROCHE·Filed 2014·Granted Aug 30, 2016·0 cites·1 claims
- 2567US2019233842A1Protein expression from multiple nucleic acidsHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2665US10151002B2Method for the selection of a long-term producing cellHOFFMANN LA ROCHE·Filed 2015·Granted Dec 11, 2018·1 cites·7 claims
- 2765US2020223912A1Humanized anti-tau(ps422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2865US2023016623A1Method for the selection of a long-term producing cell using histone acylation as markersHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2965US2023129340A1Method for producing multispecific antibodiesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3065US2020216554A1Bispecific anti-human cd20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3162US2017166923A1Protein expression from multiple nucleic acidsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3259US12312606B2Nucleic acid constructs for VA RNA transcriptionHOFFMANN LA ROCHE·Filed 2021·Granted May 27, 2025·0 cites·6 claims
- 3359US2022169729A1Method for the generation of a trivalent antibody expressing cell by targeted integration of multiple expression cassettes in a defined organizationHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3459US2022220500A1Method for the production of an antibodyHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3556US10329595B2CMV promoter and method for production of polypeptidesHOFFMANN LA ROCHE·Filed 2016·Granted Jun 25, 2019·0 cites·13 claims
- 3656US2020216553A1Method for producing multispecific antibodiesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3753US2022169730A1Method for the generation of a bivalent, bispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organizationHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3853US2019360014A1Cmv promoter and method for production of polypeptidesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3951US2022154223A1Nucleic acid constructs for simultaneous gene activationHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4050US2011229903A1Determination of immunoglobulin encoding nucleic acidGOEPFERT ULRICH·Filed 2009·Application pending·0 cites
- 4148US7892790B2Protein expression in rodent cellsHOFFMANN LA ROCHE·Filed 2006·Granted Feb 22, 2011·0 cites·13 claims
- 4247US8314225B2Heavy chain mutant leading to improved immunoglobulin productionGOEPFERT ULRICH·Filed 2008·Granted Nov 20, 2012·0 cites·20 claims
- 4346US2021139561A1Method for the generation of a multivalent, multispecific antibody expressing cells by targeted integration of multiple expression cassettes in a defined organizationHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4438US2013034852A1Method for the selection of a long-term producing cellGOEPFERT ULRICH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ulrich Goepfert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →